Mimicking Aspects of Frontotemporal Lobar Degeneration and Lou Gehrig's Disease in Rats via TDP-43 Overexpression

Jason B Tatom, David B. Wang, Robert D. Dayton, Omar Skalli, Michael Hutton, Dennis W. Dickson, Ronald L. Klein

Molecular Therapy · 2009 · 80 citations · 26 references

DOIFull text

Open access

Concepts

Abstract

Since the discovery of neuropathological lesions made of TDP-43 and ubiquitin proteins in cases of frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS), there is a burst of effort on finding related familial mutations and developing animal models. We used an adeno-associated virus (AAV) vector for human TDP-43 expression targeted to the substantia nigra (SN) of rats. Though TDP-43 was expressed mainly in neuronal nuclei as expected, it was also expressed in the cytoplasm, and dotted along the plasma membrane of neurons. Cytoplasmic staining was both diffuse and granular, indicative of preinclusion lesions, over 4 weeks. Ubiquitin deposited in the cytoplasm, specifically in the TDP-43 group, and staining for microglia was increased dose-dependently by 1–2 logs in the TDP-43 group, while neurons were selectively obliterated. Neuronal death induced by TDP-43 was pyknotic and apoptotic. TDP-43 gene transfer caused loss of dopaminergic neurons in the SN and their axons in the striatum. Behavioral motor dysfunction resulted after TDP-43 gene transfer that was vector dose-dependent and progressive over time. The cytoplasmic expression, ubiquitination, and neurodegeneration mimicked features of the TDP-43 diseases, and the gliosis, apoptosis, and motor impairment may also be relevant to TDP-43 disease forms involving nigrostriatal degeneration. Since the discovery of neuropathological lesions made of TDP-43 and ubiquitin proteins in cases of frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS), there is a burst of effort on finding related familial mutations and developing animal models. We used an adeno-associated virus (AAV) vector for human TDP-43 expression targeted to the substantia nigra (SN) of rats. Though TDP-43 was expressed mainly in neuronal nuclei as expected, it was also expressed in the cytoplasm, and dotted along the plasma membrane of neurons. Cytoplasmic staining was both diffuse and granular, indicative of preinclusion lesions, over 4 weeks. Ubiquitin deposited in the cytoplasm, specifically in the TDP-43 group, and staining for microglia was increased dose-dependently by 1–2 logs in the TDP-43 group, while neurons were selectively obliterated. Neuronal death induced by TDP-43 was pyknotic and apoptotic. TDP-43 gene transfer caused loss of dopaminergic neurons in the SN and their axons in the striatum. Behavioral motor dysfunction resulted after TDP-43 gene transfer that was vector dose-dependent and progressive over time. The cytoplasmic expression, ubiquitination, and neurodegeneration mimicked features of the TDP-43 diseases, and the gliosis, apoptosis, and motor impairment may also be relevant to TDP-43 disease forms involving nigrostriatal degeneration. IntroductionNosology of frontotemporal lobar degeneration (FTLD) is a dichotomy of proteinopathies. In one branch, there are microtubule-associated protein tau-positive neurofibrillary tangles that comprise FTLD-tau; in the other branch, there are ubiquitin and TDP- 43-positive inclusions which encompass FTLD-ubiquitin.1Kumar-Singh S Van Broeckhoven C Frontotemporal lobar degeneration: current concepts in the light of recent advances.Brain Pathol. 2007; 17: 104-114Crossref PubMed Scopus (70) Google Scholar In addition, delving deeper into the nosology, there are FTLD subjects with ubiquitinated lesions negative for tau or TDP-43, and because the tau neurofibrillary tangle lesions are also ubiquitinated, logical future nosology will likely be FTLD-tau, FTLD-TDP-43, and FTLD-protein yet to be identified.2Neumann M Pathological spectrum of frontotemporal lobar degeneration.Dement Geriatr Cogn Disord. 2008; 26: S1:1Google Scholar The clinical symptomologies are shared, for example, changes in behavior and personality and the potential for language and motor deficits including parkinsonism, along with early death.3Neary D Snowden JS Mann DM Classification and description of frontotemporal dementias.Ann NY Acad Sci. 2000; 920: 46-51Crossref PubMed Scopus (71) Google Scholar However, the neuropathologies are distinct and could require distinct palliatives specific for each type of lesion and sequelae.TDP-43, the transactive response DNA-binding protein of 43 kd, is a nuclear protein that was first described by Ou et al.4Ou SH Wu F Harrich D García-Martínez LF Gaynor RB Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs.J Virol. 1995; 69: 3584-3596Crossref PubMed Google Scholar A number of studies have attributed functions to TDP-43 including modulation of HIV-1 gene expression, exon skipping in cystic fibrosis, transcriptional regulation, exon splicing, and mRNA stability (reviewed in refs. 5Buratti E Baralle FE Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease.Front Biosci. 2008; 13: 867-878Crossref PubMed Scopus (375) Google Scholar and 6Wang IF Wu LS Shen CK TDP-43: An emerging new player in neurodegenerative diseases.Trends Mol Med. 2008; 14: 479-485Abstract Full Text Full Text PDF PubMed Scopus (90) Google Scholar). While roughly 40% of FTLD samples contain tau neurofibrillary pathology, the majority have tau-negative, ubiquitin-positive inclusions.7Pirici D Vandenberghe R Rademakers R Dermaut B Cruts M Vennekens K et al.Characterization of ubiquitinated intraneuronal inclusions in a novel Belgian frontotemporal lobar degeneration family.J Neuropathol Exp Neurol. 2006; 65: 289-301Crossref PubMed Scopus (48) Google Scholar Straight filaments in spindle-shaped intranuclear inclusions were viewed in FTLD-ubiquitin cases, although the identity of the filamentous protein was not yet known.7Pirici D Vandenberghe R Rademakers R Dermaut B Cruts M Vennekens K et al.Characterization of ubiquitinated intraneuronal inclusions in a novel Belgian frontotemporal lobar degeneration family.J Neuropathol Exp Neurol. 2006; 65: 289-301Crossref PubMed Scopus (48) Google Scholar Mutations in the gene for progranulin were found in familial FTLD-ubiquitin cases,8Baker M Mackenzie IR Pickering-Brown SM Gass J Rademakers R Lindholm C et al.Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17.Nature. 2006; 442: 916-919Crossref PubMed Scopus (1580) Google Scholar and Neumann et al.9Neumann M Sampathu DM Kwong LK Truax AC Micsenyi MC Chou TT et al.Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.Science. 2006; 314: 130-133Crossref PubMed Scopus (4383) Google Scholar showed that the ubiquitinated lesions in such cases of FTLD-ubiquitin, and in amyotrophic lateral sclerosis (ALS), contained TDP-43 (ref. 9Neumann M Sampathu DM Kwong LK Truax AC Micsenyi MC Chou TT et al.Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.Science. 2006; 314: 130-133Crossref PubMed Scopus (4383) Google Scholar). The pathogenesis of FTLD-U and ALS is thought to involve TDP-43 translocation from the nucleus and aggregation into neuronal cytoplasmic inclusions, an active topic of current research effort considering the emergence of TDP-43 as a hallmark neuropathological marker along with amyloid, tau, synuclein, and polyglutamine. The vast majority of ALS cases harbor TDP-43 neuropathology, except for the small fraction (2%) with superoxide dismutase mutations.10Mackenzie IR Bigio EH Ince PG Geser F Neumann M Cairns NJ et al.Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.Ann Neurol. 2007; 61: 427-434Crossref PubMed Scopus (707) Google ScholarIn an effort to study TDP-43-related diseases, such as FTLD-U and ALS, we generated an animal model with TDP-43 neuropathology. The adeno-associated virus (AAV) somatic cell gene transfer system has been used previously to successfully mimic aspects of Parkinson's disease11Klein RL King MA Hamby ME Meyer EM Dopaminergic cell loss induced by human A30P alpha-synuclein gene transfer to the rat substantia 13: PubMed Scopus Google Scholar and RL gene not both progressive degeneration and behavior in the PubMed Scopus Google RL expression from adeno-associated virus vector neurodegenerative disease J 2008; PubMed Scopus Google Scholar and we in study for TDP-43 The system for neurodegenerative disease to such as to after of and the potential for a and disease to study disease and was of TDP-43 is to neurons in in a specific to was to the human TDP-43 could rat ubiquitin into cytoplasmic neuropathological neurodegeneration we to the substantia nigra which a small and of and which also be with a on the of for the nigrostriatal with TDP-43 from the nigrostriatal TDP-43 cell or in cases of E C et novel progranulin with clinical and tau, and alpha-synuclein 2007; PubMed Scopus Google Scholar F NJ Kwong LK M et of in of TDP-43 in amyotrophic lateral Neurol. 2008; 65: PubMed Scopus Google F K A et neuronal and inclusions in the in amyotrophic lateral sclerosis with and 2008; PubMed Scopus Google Scholar and other TDP-43 such as C F et TDP-43 in Disord. 2008; Scholar and the and ALS of M et is deposited in the 2007; PubMed Scopus Google Scholar We of for human TDP-43 or protein in to a specific of TDP-43 on and also to ubiquitination, gliosis, and in the induced neurodegenerative disease gene of the human TDP-43 was of human TDP-43 expression was on or by after of the on a to the of the The TDP-43 mainly with nuclei with we the for TDP-43 or into the SN of rats. The TDP-43 vector was and in with vector of in 1 a there was of the nigrostriatal expression a and a to such loss of vector 1 we a in TDP-43 in the TDP-43 to their The vector to have TDP-43 as or an for TDP-43 that both rat and human TDP-43, and to the small of of of expression with with and is expected, not in the of a gene The TDP-43 expression was targeted to the as by the human specific TDP-43 the of the we used the and with cellular RL expression from adeno-associated virus vector neurodegenerative disease J 2008; PubMed Scopus Google RL vector gene transfer in the rat of and 2008; Full Text Full Text PDF PubMed Scopus Google Scholar there was with the neuronal marker with the marker or the marker protein In the with the we a in cell in the of TDP-43, not vector and ubiquitin small fraction of the TDP-43 cytoplasmic TDP-43, on the of in The staining the and in which we to be The staining in used the and nuclear staining although cytoplasmic was with TDP-43 for and or type neuronal death after TDP-43 gene while on the ubiquitin deposited into neuronal in the of the pyknotic Cytoplasmic ubiquitin not found in was found in the TDP-43 finding that TDP-43 vector gene transfer could rat ubiquitin and model a specific of pathology, which ubiquitinated neuronal cytoplasmic LK Neumann M Sampathu DM TDP-43 the forms of sporadic and familial frontotemporal lobar degeneration and motor 2007; PubMed Scopus Google Scholar the human TDP-43 expressed from the vector with the neuronal and showed expression in nuclei as as dotted along the plasma membrane of neurons TDP-43 was found in the of after TDP-43 The cytoplasmic staining in was in cases, was as in nuclear staining was found in vector the as in and staining of a vector or TDP-43 vector The on the are while neurons on TDP-43 or neuronal death in Ubiquitin of or TDP-43 Ubiquitin deposited into neuronal in the of the pyknotic in TDP-43 cases, for TDP-43 and a neuronal TDP-43 the plasma membrane in neurons in a for TDP-43 or vector was vector 1 vector TDP-43 TDP-43 gene transfer caused both for microglia and and We have previously a with RL vector gene transfer in the rat of and 2008; Full Text Full Text PDF PubMed Scopus Google Scholar and in and staining with to in although the TDP-43 was and to the with which showed increased cell for the and TDP-43 in in as as specifically after TDP-43 gene the gliosis, we viewed a and of staining after or TDP-43 The from the by with of from the in the vector However, distinct gliosis, from the in the TDP-43 group, was increased both and The and caused by TDP-43 gene transfer 4 to be We the 4 by an in the from for each the was to the with the was with the SN The for the were as and was a 40% in the to the and a to by TDP-43 on the We TDP-43 vector to vector and TDP-43 the that TDP-43 was from and that there was a the TDP-43 The after TDP-43 vector with the of expression from RL expression from adeno-associated virus vector neurodegenerative disease J 2008; PubMed Scopus Google Scholar although the cell loss could also have to the and induced by with the in vector or TDP-43 vector is a in the number of microglia and also an in their of protein for in vector or TDP-43 vector are and after TDP-43 gene of and vector of vector of on nuclear DNA with the TDP-43 vector not in there was an of of apoptosis, from of nuclei to was for in TDP-43 subjects with with the and with light over nuclei in nuclei as in for with was with a with a after TDP-43 not after of as in of and vector of vector nigrostriatal TDP-43 vector in the SN 4 weeks. The loss of neurons in the SN was with the neuronal marker the in cell after TDP-43 and the neurons in the SN were to the dopaminergic neuronal loss with vector along with to and were to in in the SN from to lesions TDP-43 was to vector to dose-dependent the 1 and of vector the of in the SN to samples The vector in 1 were by that showed and in which showed in the TDP-43 to in the TDP-43 to the and in the TDP-43 to the TDP-43 The of the rat SN neurodegeneration in a dose-dependent specifically in to In with the in the of nigrostriatal axons in the was by TDP-43 gene transfer the as an the gene transfer not In the TDP-43 and in a dose-dependent the vector in 1 were for there was an and in the in the TDP-43 to the in the TDP-43 to the and in the TDP-43 to the TDP-43 for gene transfer in the substantia nigra in the SN in 4 after a of vector of the protein there was in in a is from the of and TDP-43 a of 1 and TDP-43 a of was and of the SN with TDP-43 gene transfer 4 on the gene transfer dopaminergic vector for neurons and in vector for neurons and in of 4 for the vector TDP-43 vector for neurons and in in a new gene transfer in the each the is the and the protein or TDP-43 vector 1 vector vector While vector not in the of axons in the the TDP-43 to to the and in a dose-dependent rat nigrostriatal system a as as in and RL gene not both progressive degeneration and behavior in the PubMed Scopus Google Scholar were for to the cell loss was The TDP-43 vector gene transfer the with a loss of in the 4 to was the or in the TDP-43 or vector A which was progressive and 4 in the TDP-43 group, which the of lesions for of behavior after TDP-43 gene protein vector group, and 4 weeks. vector TDP-43 as in TDP-43 as in was a in the TDP-43 group, and not weeks. system was in aspects of the TDP-43 diseases, FTLD-ubiquitin, and ALS, involving of nigrostriatal E C et novel progranulin with clinical and tau, and alpha-synuclein 2007; PubMed Scopus Google F NJ Kwong LK M et of in of TDP-43 in amyotrophic lateral Neurol. 2008; 65: PubMed Scopus Google F K A et neuronal and inclusions in the in amyotrophic lateral sclerosis with and 2008; PubMed Scopus Google C F et TDP-43 in Disord. 2008; M et is deposited in the 2007; PubMed Scopus Google Scholar TDP-43 was expressed in both the nucleus and the of rat a response in the the model for the cytoplasmic lesions of FTLD-ubiquitin and TDP-43, in a specific to induced gliosis, and progressive motor to be the induced disease in a TDP-43 disease as there are forms with While animal system human diseases, the rat model a to the such as the and motor neurons of the and relevant to ALS, and of and that TDP-43, which will the TDP-43 disease and a TDP-43 was expressed in the of neurons and the cytoplasmic was diffuse and granular, with We that TDP-43 inclusions 4 weeks. nuclear cytoplasmic Van Kwong LK EM et TDP-43 in the of TDP-43 in 2008; Full Text Full Text PDF PubMed Scopus Google Scholar as could other familial forms of TDP-43 (ref. MA S K D et in familial motor Neurol. 2008; PubMed Scopus Google or E Baralle F R et of TAR DNA 2007; PubMed Scopus Google Scholar We be in TDP-43 for to sporadic disease forms and to study that cytoplasmic from a we be in a protein that could to TDP-43 such as M S C A EM et are for of protein with neurodegenerative 2007; PubMed Scopus Google Scholar or to TDP-43 RL is for substantia nigra neurons in a tau gene transfer neurodegeneration 2006; PubMed Scopus Google Scholar or an M M R A et negative as gene for Parkinson's Acad PubMed Scopus Google Scholar considering the nuclei in the TDP-43 induced by TDP-43 was to study and previously with and tau gene We have of with gene transfer to RL vector gene transfer in the rat of and 2008; Full Text Full Text PDF PubMed Scopus Google Scholar and induced by tau to RL and neurodegeneration in after tau gene the Scholar the caused by TDP-43 in study was to to the to TDP-43 expression or the neurodegeneration induced by However, we successfully the gliosis, the and the The the are nigrostriatal system as a of neuronal cell loss and motor behavior while there is for TDP-43 in E C et novel progranulin with clinical and tau, and alpha-synuclein 2007; PubMed Scopus Google F NJ Kwong LK M et of in of TDP-43 in amyotrophic lateral Neurol. 2008; 65: PubMed Scopus Google F K A et neuronal and inclusions in the in amyotrophic lateral sclerosis with and 2008; PubMed Scopus Google C F et TDP-43 in Disord. 2008; M et is deposited in the 2007; PubMed Scopus Google Scholar We to study TDP-43 relevant to FTLD-ubiquitin and disease to a new small In light of functions of the to and IF Wu LS Shen CK TDP-43: An emerging new player in neurodegenerative diseases.Trends Mol Med. 2008; 14: 479-485Abstract Full Text Full Text PDF PubMed Scopus (90) Google IF Wu LS Shen CK TDP-43, the protein of is a neuronal 2008; PubMed Scopus Google Scholar not to membrane TDP-43 expression the also be used for and and The human TDP-43 was from The TDP-43 was into an expression with The was used to We of the TDP-43 or a into as RL expression from adeno-associated virus vector neurodegenerative disease J 2008; PubMed Scopus Google Scholar were with TDP-43 or along with to by the The cell was to a of after and for 1 The was with and and by The were by into were and were by The of the TDP-43 was vector and the was were made by with the and from were with a of and 1 a of 1 were a to a to a a of with of The for the SN were and C The in Scholar The in the for one the was The was and the animal was on a it to from the to animal by and as as the of for and of were and in with and to a The SN was and on The samples were in with and the fraction was by and was by and to with the with protein in each The for the were TDP-43 or The was from and the from for the TDP-43 TDP-43 for protein for or for for neuronal nuclei and were with by in The was and in 4 were in a of 4 were on a with a were for and on were 4 on a was with for The were in and for in and for staining were from for 1 The were with and with for The was in and on the were in a of and and with were in and with for by and with DNA from of an of was used as the The a of and for of of DNA generated apoptosis, and The number of SN neurons was by the the SN were for each were in a and from the The was to for RL expression from adeno-associated virus vector neurodegenerative disease J 2008; PubMed Scopus Google for and the were for The specific staining in the was the The were and for of staining The of the to the was for each The for each animal was an from was for for in the SN were for the and with a were with the with specific staining over the the for the The of for each was for the were with in The was the in an system from for studies that by after and that a is to a is are expressed as and or as with with vector of and the marker in of and the marker protein in of and neuronal in cell was with a for and substantia nigra substantia nigra with TDP-43 gene transfer a in cell by 4 vector of vector from from as TDP-43 increased of substantia with staining with in with a of 1 vector of or TDP-43 staining with in with a of 1 vector of or TDP-43 TDP-43 induced to from the in the substantia nigra in with in staining and the was with a with induced by TDP-43 vector The was vector and the was vector both staining was in the TDP-43 to or and there was staining in the TDP-43 to the was with a with TDP-43 with a for neuronal vector of vector TDP-43 with a for neuronal vector of vector substantia nigra from from the as TDP-43 into the SN the vast majority of neurons in the substantia nigra substantia nigra IntroductionNosology of frontotemporal lobar degeneration (FTLD) is a dichotomy of proteinopathies. In one branch, there are microtubule-associated protein tau-positive neurofibrillary tangles that comprise FTLD-tau; in the other branch, there are ubiquitin and TDP- 43-positive inclusions which encompass FTLD-ubiquitin.1Kumar-Singh S Van Broeckhoven C Frontotemporal lobar degeneration: current concepts in the light of recent advances.Brain Pathol. 2007; 17: 104-114Crossref PubMed Scopus (70) Google Scholar In addition, delving deeper into the nosology, there are FTLD subjects with ubiquitinated lesions negative for tau or TDP-43, and because the tau neurofibrillary tangle lesions are also ubiquitinated, logical future nosology will likely be FTLD-tau, FTLD-TDP-43, and FTLD-protein yet to be identified.2Neumann M Pathological spectrum of frontotemporal lobar degeneration.Dement Geriatr Cogn Disord. 2008; 26: S1:1Google Scholar The clinical symptomologies are shared, for example, changes in behavior and personality and the potential for language and motor deficits including parkinsonism, along with early death.3Neary D Snowden JS Mann DM Classification and description of frontotemporal dementias.Ann NY Acad Sci. 2000; 920: 46-51Crossref PubMed Scopus (71) Google Scholar However, the neuropathologies are distinct and could require distinct palliatives specific for each type of lesion and sequelae.TDP-43, the transactive response DNA-binding protein of 43 kd, is a nuclear protein that was first described by Ou et al.4Ou SH Wu F Harrich D García-Martínez LF Gaynor RB Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs.J Virol. 1995; 69: 3584-3596Crossref PubMed Google Scholar A number of studies have attributed functions to TDP-43 including modulation of HIV-1 gene expression, exon skipping in cystic fibrosis, transcriptional regulation, exon splicing, and mRNA stability (reviewed in refs. 5Buratti E Baralle FE Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease.Front Biosci. 2008; 13: 867-878Crossref PubMed Scopus (375) Google Scholar and 6Wang IF Wu LS Shen CK TDP-43: An emerging new player in neurodegenerative diseases.Trends Mol Med. 2008; 14: 479-485Abstract Full Text Full Text PDF PubMed Scopus (90) Google Scholar). While roughly 40% of FTLD samples contain tau neurofibrillary pathology, the majority have tau-negative, ubiquitin-positive inclusions.7Pirici D Vandenberghe R Rademakers R Dermaut B Cruts M Vennekens K et al.Characterization of ubiquitinated intraneuronal inclusions in a novel Belgian frontotemporal lobar degeneration family.J Neuropathol Exp Neurol. 2006; 65: 289-301Crossref PubMed Scopus (48) Google Scholar Straight filaments in spindle-shaped intranuclear inclusions were viewed in FTLD-ubiquitin cases, although the identity of the filamentous protein was not yet known.7Pirici D Vandenberghe R Rademakers R Dermaut B Cruts M Vennekens K et al.Characterization of ubiquitinated intraneuronal inclusions in a novel Belgian frontotemporal lobar degeneration family.J Neuropathol Exp Neurol. 2006; 65: 289-301Crossref PubMed Scopus (48) Google Scholar Mutations in the gene for progranulin were found in familial FTLD-ubiquitin cases,8Baker M Mackenzie IR Pickering-Brown SM Gass J Rademakers R Lindholm C et al.Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17.Nature. 2006; 442: 916-919Crossref PubMed Scopus (1580) Google Scholar and Neumann et al.9Neumann M Sampathu DM Kwong LK Truax AC Micsenyi MC Chou TT et al.Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.Science. 2006; 314: 130-133Crossref PubMed Scopus (4383) Google Scholar showed that the ubiquitinated lesions in such cases of FTLD-ubiquitin, and in amyotrophic lateral sclerosis (ALS), contained TDP-43 (ref. 9Neumann M Sampathu DM Kwong LK Truax AC Micsenyi MC Chou TT et al.Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.Science. 2006; 314: 130-133Crossref PubMed Scopus (4383) Google Scholar). The pathogenesis of FTLD-U and ALS is thought to involve TDP-43 translocation from the nucleus and aggregation into neuronal cytoplasmic inclusions, an active topic of current research effort considering the emergence of TDP-43 as a hallmark neuropathological marker along with amyloid, tau, synuclein, and polyglutamine. The vast majority of ALS cases harbor TDP-43 neuropathology, except for the small fraction (2%) with superoxide dismutase mutations.10Mackenzie IR Bigio EH Ince PG Geser F Neumann M Cairns NJ et al.Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.Ann Neurol. 2007; 61: 427-434Crossref PubMed Scopus (707) Google ScholarIn an effort to study TDP-43-related diseases, such as FTLD-U and ALS, we generated an animal model with TDP-43 neuropathology. The adeno-associated virus (AAV) somatic cell gene transfer system has been used previously to successfully mimic aspects of Parkinson's disease11Klein RL King MA Hamby ME Meyer EM Dopaminergic cell loss induced by human A30P alpha-synuclein gene transfer to the rat substantia 13: PubMed Scopus Google Scholar and RL gene not both progressive degeneration and behavior in the PubMed Scopus Google RL expression from adeno-associated virus vector neurodegenerative disease J 2008; PubMed Scopus Google Scholar and we in study for TDP-43 The system for neurodegenerative disease to such as to after of and the potential for a and disease to study disease and was of TDP-43 is to neurons in in a specific to was to the human TDP-43 could rat ubiquitin into cytoplasmic neuropathological neurodegeneration we to the substantia nigra which a small and of and which also be with a on the of for the nigrostriatal with TDP-43 from the nigrostriatal TDP-43 cell or in cases of E C et novel progranulin with clinical and tau, and alpha-synuclein 2007; PubMed Scopus Google Scholar F NJ Kwong LK M et of in of TDP-43 in amyotrophic lateral Neurol. 2008; 65: PubMed Scopus Google F K A et neuronal and inclusions in the in amyotrophic lateral sclerosis with and 2008; PubMed Scopus Google Scholar and other TDP-43 such as C F et TDP-43 in Disord. 2008; Scholar and the and ALS of M et is deposited in the 2007; PubMed Scopus Google Scholar We of for human TDP-43 or protein in to a specific of TDP-43 on and also to ubiquitination, gliosis, and in the induced neurodegenerative disease

References

26